• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏自主神经控制受损与肺动脉高压的疾病严重程度相关。

Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension.

作者信息

Wensel R, Jilek C, Dörr M, Francis D P, Stadler H, Lange T, Blumberg F, Opitz C, Pfeifer M, Ewert R

机构信息

Dept of Internal Medicine II, Universtätsklinikum Regensburg, Regensburg, Germany.

出版信息

Eur Respir J. 2009 Oct;34(4):895-901. doi: 10.1183/09031936.00145708. Epub 2009 May 14.

DOI:10.1183/09031936.00145708
PMID:19443531
Abstract

Pulmonary arterial hypertension (PAH) results in chronic right heart failure, which is associated with an increase in sympathetic tone. This may adversely affect cardiac autonomic control. We investigated the changes in cardiac autonomic nervous activity in relation to disease severity in patients with PAH. In 48 patients with PAH (median World Health Organization class III, pulmonary artery pressure 52+/-14 mmHg, pulmonary vascular resistance 1,202+/-718 dyn x s x cm(-5), cardiac index 2.0+/-0.8 L x min(-1) x m(-2)) and 41 controls, cardiac autonomic nervous activity was evaluated by measurement of heart rate variability (HRV) and baroreflex sensitivity. All patients underwent cardiopulmonary exercise testing (peak oxygen uptake 13.2+/-5.1 mL x kg(-1) x min(-1), minute ventilation/carbon dioxide production slope 47+/-16). In patients with PAH, spectral power of HRV was reduced in the high-frequency (239+/-64 versus 563+/-167 ms2), low-frequency (245+/-58 versus 599+/-219 ms2) and very low-frequency bands (510+/-149 versus 1106+/-598 ms2; all p<0.05). Baroreflex sensitivity was also blunted (5.8+/-0.6 versus 13.9+/-1.2 ms x mmHg(-1); p<0.01). The reduction in high-frequency (r = 0.3, p = 0.04) and low-frequency (r = 0.33, p = 0.02) spectral power and baroreflex sensitivity (r = 0.46, p<0.01) was related to the reduction in peak oxygen uptake. Patients with PAH have a marked alteration in cardiac autonomic control that is related to exercise capacity and may, therefore, serve as an additional marker of disease severity.

摘要

肺动脉高压(PAH)会导致慢性右心衰竭,这与交感神经张力增加有关。这可能会对心脏自主神经控制产生不利影响。我们研究了PAH患者心脏自主神经活动与疾病严重程度的关系。在48例PAH患者(世界卫生组织心功能分级中位数为III级,肺动脉压52±14 mmHg,肺血管阻力1202±718 dyn·s·cm⁻⁵,心脏指数2.0±0.8 L·min⁻¹·m⁻²)和41例对照组中,通过测量心率变异性(HRV)和压力反射敏感性来评估心脏自主神经活动。所有患者均进行了心肺运动试验(峰值摄氧量13.2±5.1 mL·kg⁻¹·min⁻¹,分钟通气量/二氧化碳产生斜率47±16)。在PAH患者中,HRV的高频(239±64对563±167 ms²)、低频(245±58对599±219 ms²)和极低频波段(510±149对1106±598 ms²;均p<0.05)的频谱功率降低。压力反射敏感性也减弱(5.8±0.6对13.9±1.2 ms·mmHg⁻¹;p<0.01)。高频(r = 0.3,p = 0.04)和低频(r = 0.33,p = 0.02)频谱功率以及压力反射敏感性(r = 0.46,p<0.01)的降低与峰值摄氧量的降低有关。PAH患者的心脏自主神经控制有明显改变,这与运动能力有关,因此可能作为疾病严重程度的一个额外标志物。

相似文献

1
Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension.心脏自主神经控制受损与肺动脉高压的疾病严重程度相关。
Eur Respir J. 2009 Oct;34(4):895-901. doi: 10.1183/09031936.00145708. Epub 2009 May 14.
2
Differences in hemodynamic parameters and exercise capacity between patients with pulmonary arterial hypertension and chronic heart failure.肺动脉高压与慢性心力衰竭患者血液动力学参数和运动能力的差异。
J Cardiopulm Rehabil Prev. 2012 Nov-Dec;32(6):379-85. doi: 10.1097/HCR.0b013e318272bc0b.
3
Impairment of autonomic nervous system activity in patients with pulmonary arterial hypertension: a case control study.肺动脉高压患者自主神经系统活动受损:一项病例对照研究。
J Card Fail. 2009 Dec;15(10):882-9. doi: 10.1016/j.cardfail.2009.06.001. Epub 2009 Jul 16.
4
Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension.右心室储备对肺动脉高压患者运动能力和生存的影响。
Eur J Heart Fail. 2013 Jul;15(7):771-5. doi: 10.1093/eurjhf/hft044. Epub 2013 Mar 18.
5
Implications of exercise-induced pulmonary arterial hypertension.运动性肺动脉高压的影响。
Med Sci Sports Exerc. 2011 Jun;43(6):983-9. doi: 10.1249/MSS.0b013e318204cdac.
6
[Cardiac autonomic responses to exercise testing in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者运动试验中的心脏自主神经反应]
Anadolu Kardiyol Derg. 2010 Apr;10(2):104-10. doi: 10.5152/akd.2010.032.
7
Physiological response to the six-minute walk test in pulmonary arterial hypertension.肺动脉高压患者对六分钟步行试验的生理反应
Eur Respir J. 2005 Oct;26(4):667-72. doi: 10.1183/09031936.05.00031505.
8
Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension.肺动脉高压患者交感神经活动的微神经图与心率频谱指标之间的不一致性。
Heart. 2009 May;95(9):754-8. doi: 10.1136/hrt.2008.157115. Epub 2009 Jan 16.
9
Exercise oscillatory ventilation in heart failure and in pulmonary arterial hypertension.心力衰竭和肺动脉高压中的运动振荡通气
Int J Cardiol. 2016 Jan 1;202:736-40. doi: 10.1016/j.ijcard.2015.09.087. Epub 2015 Sep 26.
10
Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.特发性肺动脉高压和先天性心脏病相关肺动脉高压患儿的肺动脉顺应性:与肺血管阻力、运动能力和生存的关系。
Am Heart J. 2011 Sep;162(3):562-8. doi: 10.1016/j.ahj.2011.06.014. Epub 2011 Aug 11.

引用本文的文献

1
Heart Rate Variability in Pulmonary Arterial Hypertension.肺动脉高压中的心率变异性
Pulm Circ. 2025 Feb 8;15(1):e70048. doi: 10.1002/pul2.70048. eCollection 2025 Jan.
2
Heart rate variability in pulmonary vascular disease at altitude: a randomised trial.高原地区肺血管疾病患者的心率变异性:一项随机试验。
ERJ Open Res. 2024 Oct 28;10(5). doi: 10.1183/23120541.00235-2024. eCollection 2024 Sep.
3
Cardiac Arrhythmias in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Mechanistic Insights, Pathophysiology, and Outcomes.
肺动脉高压和慢性血栓栓塞性肺动脉高压中的心律失常:机制见解、病理生理学和结局。
Ann Noninvasive Electrocardiol. 2024 Sep;29(5):e70010. doi: 10.1111/anec.70010.
4
Carotid Baroreceptor Stimulation Improves Pulmonary Arterial Remodeling and Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.颈动脉压力感受器刺激可改善肺动脉高压中的肺动脉重塑和右心室功能障碍。
JACC Basic Transl Sci. 2024 Apr 22;9(4):475-492. doi: 10.1016/j.jacbts.2024.01.012. eCollection 2024 Apr.
5
ACE2 overexpression in corticotropin-releasing-hormone cells offers protection against pulmonary hypertension.促肾上腺皮质激素释放激素细胞中ACE2的过表达可预防肺动脉高压。
Front Neurosci. 2023 Aug 10;17:1223733. doi: 10.3389/fnins.2023.1223733. eCollection 2023.
6
Continuous long-term heart rate variability and risk assessment in pulmonary hypertension.肺动脉高压的连续长期心率变异性与风险评估。
Open Heart. 2023 Jun;10(1). doi: 10.1136/openhrt-2023-002302.
7
Physiological and Psychological Response to Acute Mental Stress in Female Patients Affected by Chronic Pulmonary Arterial Hypertension: An Explorative Controlled Pilot Trial.慢性肺动脉高压女性患者对急性精神应激的生理和心理反应:一项探索性对照试验
Pharmaceuticals (Basel). 2023 Mar 27;16(4):493. doi: 10.3390/ph16040493.
8
Thoracic Spinal Cord Neuroinflammation as a Novel Therapeutic Target in Pulmonary Hypertension.胸部脊髓神经炎症作为肺动脉高压的一个新的治疗靶点。
Hypertension. 2023 Jun;80(6):1297-1310. doi: 10.1161/HYPERTENSIONAHA.122.20782. Epub 2023 Apr 24.
9
Hyperoxia improves exercise capacity in cardiopulmonary disease: a series of randomised controlled trials.高氧改善心肺疾病患者的运动能力:一系列随机对照试验
ERJ Open Res. 2023 Mar 27;9(2). doi: 10.1183/23120541.00563-2022. eCollection 2023 Mar.
10
New Drugs and Therapies in Pulmonary Arterial Hypertension.新型药物和疗法在肺动脉高压中的应用。
Int J Mol Sci. 2023 Mar 19;24(6):5850. doi: 10.3390/ijms24065850.